Table 5 Association of the absolute CD19+ B cells and CD19 + CD25+ Bregs count with IL-10, TGF-β1 and IFN-γ in healthy controls (HC), end-stage renal disease patients (ESRD) and renal transplant recipients (Tx)
| Â | HC | ESRD | Tx | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CD19/μl | CD19 + CD25+/μl | CD19/μl | CD19 + CD25+/μl | CD19/μl | CD19 + CD25+/μl | |||||||
r | p | r | p | r | p | r | p | r | p | r | p | |
IL-10 (pg/ml) | 0.082 | 0.662 | −0.070 | 0.708 | −0.210 | 0.404 | −0.283 | 0.255 | −0.299 | 0.004 | −0.121 | 0.258 |
TGF-β1 (pg/ml) | 0.039 | 0.835 | 0.006 | 0.973 | −0.243 | 0.332 | −0.146 | 0.562 | 0.155 | 0.144 | 0.255 | 0.015 |
IFN-γ (pg/ml) | −0.126 | 0.500 | 0.170 | 0.361 | 0.102 | 0.687 | −0.119 | 0.637 | −0.346 | 0.001 | 0.055 | 0.606 |